Credit Suisse analyst Jerry Su downgrades Himax Technologies (NASDAQ:HIMX) from Outperform to Neutral and announces $7 price target.
BELLUS Health Shares Slide On Public Offering Of Shares In Canada And US
BELLUS Health Inc (NASDAQ:BLU) (TSX:BLU) has filed a preliminary prospectus supplement to its amended and restated short form base shelf prospectus dated…